Targeted therapy for Hodgkin lymphoma

Targeted therapies (also called biological therapies) are drugs that use unique features of the cancer to find and destroy cancer cells. These drugs only target the cancer cells, so they have less effect on healthy cells.

This type of treatment is not often used to treat Hodgkin lymphoma. Some people have a targeted therapy called rituximab to treat NLPHL. Another drug called brentuximab vedotin (Adcetris®) may be used as part of the treatment for classical Hodgkin lymphoma that has come back. Sometimes targeted therapy drugs are given in a research trial to find out how effective they are.

Back to Targeted (biological) therapies

Monoclonal antibodies

Monoclonal antibodies can attach themselves to cancer cells to prevent them from growing.